2361 — Sinohealth Holdings Share Price
- HK$1.32bn
- HK$731.97m
- CNY403.73m
- 99
- 64
- 19
- 68
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 12.14 | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | -10.8% | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.75 | ||
Price to Tang. Book | 1.78 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 3.07 | ||
EV to EBITDA | 5.37 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 16.81% | ||
Return on Equity | 15.65% | ||
Operating Margin | 29.91% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | CNYm | 202.07 | 324.17 | 356.67 | 396.19 | 403.73 | 527.24 | 587.17 | 17.83% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +19.89 | +39.14 | -35.33 | +78 | +24.82 | -19.54 | +12.5 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Sinohealth Holdings Ltd is a China-based investment holding company. The Company primarily provides data insight solutions, data-driven publications and events and software as a service (SaaS) products. Data insight solutions include growth and investment decision solutions and data-driven marketing solutions. Data-driven publications and events include combination of publications, precision connections and exhibition services. SaaS products include Smart Decision Cloud, Smart Retail Cloud, Smart Health Management Cloud and Smart Medical Cloud. The Company mainly operates its businesses in the domestic and overseas markets.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 4th, 2019
- Public Since
- July 12th, 2022
- No. of Employees
- 768
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 409,078,000

- Address
- Room 1111, No.5 Wangjiang, GUANGZHOU
- Web
- https://www.sinohealth.cn/
- Phone
- Auditors
- Ernst & Young
Upcoming Events for 2361
Sinohealth Holdings Ltd Annual Shareholders Meeting
Dividend For 2361.HK - 0.1200 HKD
Similar to 2361
China 21st Century Education
Stock Exchange of Hong Kong Limited
Ab Builders
Stock Exchange of Hong Kong Limited
Allied Sustainability and Environmental Consultants
Stock Exchange of Hong Kong Limited
A.Plus group
Stock Exchange of Hong Kong Limited
AP Rentals Holdings
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 23:16 UTC, shares in Sinohealth Holdings are trading at HK$3.23. This share price information is delayed by 15 minutes.
Shares in Sinohealth Holdings last closed at HK$3.23 and the price had moved by -38.44% over the past 365 days. In terms of relative price strength the Sinohealth Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -37.73% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Sinohealth Holdings dividend yield is 3.72% based on the trailing twelve month period.
Last year, Sinohealth Holdings paid a total dividend of CNY0.11, and it currently has a trailing dividend yield of 3.72%.Looking ahead, shares in Sinohealth Holdings are due to go ex-dividend on 2025-06-23 and the next dividend pay date is 2025-09-25.
Sinohealth Holdings are due to go ex-dividend on 2025-06-23 and the next dividend pay date is 2025-09-25. The historic dividend yield on Sinohealth Holdings shares is currently 3.72%.
To buy shares in Sinohealth Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$3.23, shares in Sinohealth Holdings had a market capitalisation of HK$1.32bn.
Here are the trading details for Sinohealth Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2361
Based on an overall assessment of its quality, value and momentum Sinohealth Holdings is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sinohealth Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -21.78%.
As of the last closing price of HK$3.23, shares in Sinohealth Holdings were trading -24.41% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sinohealth Holdings PE ratio based on its reported earnings over the past 12 months is 12.14. The shares last closed at HK$3.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Sinohealth Holdings' directors